Suven Life Sciences Limited (BOM:530239)
India · Delayed Price · Currency is INR 136.90
+1.65 (1.22%)
At close: Jan 22, 2026
Suven Life Sciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -2,119 | -1,607 | -1,051 | -1,183 | -1,220 | -721.51 | Upgrade |
Depreciation & Amortization | 58.79 | 57.92 | 64.75 | 65.17 | 43.7 | 43.31 | Upgrade |
Other Amortization | 0.3 | 0.3 | 0.27 | 0.26 | 0.23 | 0.15 | Upgrade |
Loss (Gain) From Sale of Investments | -61.99 | -49.76 | -45.49 | -17.92 | -3.56 | -0.61 | Upgrade |
Stock-Based Compensation | 12.75 | 12.75 | - | - | - | - | Upgrade |
Other Operating Activities | -3.13 | -55.45 | -192.35 | -139.46 | -56.52 | -134.54 | Upgrade |
Change in Accounts Receivable | 4.11 | -0.51 | -4.79 | 4.91 | 4.64 | 5.09 | Upgrade |
Change in Inventory | 4.64 | 4.71 | -7.08 | 0.22 | 1.19 | -1.42 | Upgrade |
Change in Accounts Payable | 4.29 | 31.59 | 4.03 | -3.22 | -10.09 | -27.86 | Upgrade |
Change in Other Net Operating Assets | 327.03 | 64.86 | 76.73 | 112.9 | -35.02 | -122.85 | Upgrade |
Operating Cash Flow | -1,772 | -1,541 | -1,155 | -1,160 | -1,275 | -960.24 | Upgrade |
Capital Expenditures | -393.37 | -372.76 | - | -28.95 | -197.72 | -63.05 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 24.21 | - | - | - | Upgrade |
Investment in Securities | -387.79 | 1,871 | 757.32 | -2,512 | -447.21 | 912.77 | Upgrade |
Other Investing Activities | -417.92 | 51.59 | 162.83 | 62.64 | 8.14 | -297.11 | Upgrade |
Investing Cash Flow | -1,199 | 1,550 | 944.36 | -2,478 | -222.29 | 558.4 | Upgrade |
Long-Term Debt Repaid | - | -7.1 | -8.96 | -16.03 | -15.55 | -12.49 | Upgrade |
Total Debt Repaid | -2.44 | -7.1 | -8.96 | -16.03 | -15.55 | -12.49 | Upgrade |
Net Debt Issued (Repaid) | -2.44 | -7.1 | -8.96 | -16.03 | -15.55 | -12.49 | Upgrade |
Issuance of Common Stock | 2,995 | - | - | 3,974 | 1,476 | - | Upgrade |
Other Financing Activities | -0.08 | -0.47 | -1.58 | -2.62 | -3.95 | 361.05 | Upgrade |
Financing Cash Flow | 2,993 | -7.56 | -10.54 | 3,955 | 1,457 | 348.56 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - | - | Upgrade |
Net Cash Flow | 21.72 | 0.93 | -220.87 | 317.46 | -40.75 | -53.28 | Upgrade |
Free Cash Flow | -2,165 | -1,914 | -1,155 | -1,189 | -1,473 | -1,023 | Upgrade |
Free Cash Flow Margin | -3693.58% | -2875.39% | -987.51% | -874.42% | -1232.64% | -727.12% | Upgrade |
Free Cash Flow Per Share | -9.84 | -8.78 | -5.29 | -6.67 | -10.93 | -8.04 | Upgrade |
Cash Interest Paid | 0.08 | 0.47 | 1.58 | 2.62 | 3.95 | 8.15 | Upgrade |
Cash Income Tax Paid | - | -6.05 | -61.77 | 11.02 | 5.2 | 11.45 | Upgrade |
Levered Free Cash Flow | -1,327 | -1,252 | -684.75 | -826.32 | -616.13 | -702.41 | Upgrade |
Unlevered Free Cash Flow | -1,327 | -1,252 | -683.76 | -824.52 | -612.81 | -697.32 | Upgrade |
Change in Working Capital | 340.07 | 100.65 | 68.89 | 114.81 | -39.27 | -147.04 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.